¶áǯÁý¤¨¤Æ¤¤¤ë¡ÖµÕήÀ­¿©Æ»±ê¡× ¸¶°ø¤È¼£ÎÅË¡¤ò¾Ã²½´ïÆâ²ÊÀìÌç°å¤¬²òÀâ

¼Ì¿¿³ÈÂç (Á´4Ëç)

À¸³è½¬´·¤ÎÊѲ½¤Ë¤è¤Ã¤Æ¶áǯÁý²Ã·¹¸þ¤Ë¤¢¤ë¡ÖµÕήÀ­¿©Æ»±ê¡×¤Ç¤¹¤¬¡¢»þ¤Ë¿©Æ»Á£¤¬¤ó¤Îȯ¾É¤Ë´Ø¤ï¤ë¤³¤È¤â¤¢¤ë¤È¤¤¤¤¤Þ¤¹¡£ÉáÃʤɤΤ褦¤Ê¤³¤È¤Ëµ¤¤ò¤Ä¤±¤¿¤é¤è¤¤¤«¡¢Í½Ëɤ伣ÎÅË¡¤Ë¤Ä¤¤¤Æ¡¢¾Ã²½´ïÆâ²ÊÀìÌç°å¤ÎÀв¬ÀèÀ¸¤Ë²òÀ⤷¤Æ¤â¤é¤¤¤Þ¤·¤¿¡£

µÕήÀ­¿©Æ»±ê¤Î´µ¼Ô¤µ¤ó¤ÏÁý¤¨¤Æ¤¤¤ë

ÊÔ½¸Éô

¤Þ¤º¤ÏµÕήÀ­¿©Æ»±ê¤Ë¤Ä¤¤¤Æ¶µ¤¨¤Æ¤¯¤À¤µ¤¤¡£

Àв¬ÀèÀ¸

µÕήÀ­¿©Æ»±ê¤Ï¡¢°ß»À¤ò´Þ¤à°ß¤ÎÆâÍÆʪ¤¬¿©Æ»¤ØµÕή¤¹¤ë¤³¤È¤Ë¤è¤Ã¤Æ¡¢¶»¾Æ¤±¤äÆÝ»À¾É¾õ¡Ê»À¤Ã¤Ñ¤¤¤â¤Î¤ä¶ì¤¤¤â¤Î¤¬¹þ¤ß¾å¤²¤Æ¤¯¤ë¤è¤¦¤Ê¾É¾õ¡Ë¤Ê¤É¤ò°ú¤­µ¯¤³¤¹¼À´µ¤Ç¡¢´µ¼Ô¿ô¤ÏÁý²Ã¤Î°ìÅÓ¤òé¤Ã¤Æ¤¤¤Þ¤¹¡£¡ÖµÕήÀ­¿©Æ»±ê¡×¤È¤¤¤¦¸ÀÍÕ¤ò°ìÅÙ¤Ïʹ¤¤¤¿¤³¤È¤¬¤¢¤ë¡¢¤È¤¤¤¦¿Í¤â°ÊÁ°¤ÈÈæ¤Ù¤Æ¤È¤Æ¤âÁý¤¨¤¿¤è¤¦¤Ë´¶¤¸¤Æ¤¤¤Þ¤¹¡£

ÊÔ½¸Éô

¤Ê¤¼µÕήÀ­¿©Æ»±ê¤Î´µ¼Ô¿ô¤ÏÁý¤¨¤Æ¤¤¤ë¤Î¤Ç¤¹¤«¡©

Àв¬ÀèÀ¸

¥Ô¥í¥ê¶Ý´¶À÷Ψ¤ÎÄã²¼¤Ê¤É¤Ë¤è¤Ã¤Æ¡¢ÆüËܿͤΰ߻ÀʬÈçǽÎϤÏÁý²Ã·¹¸þ¤Ë¤¢¤ê¤Þ¤¹¡Ê¢¨1¡Ë¡£¤Þ¤¿¡¢¹â»éËÿ©¤ä²á¿©¤Ê¤É¤Î¿©À¸³è¤ÎÊѲ½¤äÈîËþ¼Ô¤ÎÁý²Ã¤Ê¤É¤Ë¤è¤ê¡¢°ß»À¤ÎµÕή¤¬Áý²Ã¤·¤Æ¤¤¤Þ¤¹¡£°ÊÁ°¤Ï¹ø¤Î¶Ê¤¬¤Ã¤¿¹âÎð¼Ô¤Ë¿¤¤¼À´µ¤Ç¤·¤¿¤¬¡¢¸½ºß¤ÏĹ»þ´Ö¤Î¥Ç¥¹¥¯¥ïー¥¯¤Ë¤è¤ë»ÑÀª¤Î°­²½¤ä¿ç̲ÉÔ­¡¢¥¹¥È¥ì¥¹¤ÎÁý²Ã¤Ëȼ¤¤¡¢¼ã¤¤Êý¤Ç¤â¾É¾õ¤òÁʤ¨¤ëÊý¤¬Áý¤¨¤Æ¤¤¤Þ¤¹¡£

1. ÆüËܾò½´ïɳزñ. °ß¿©Æ»µÕή¾É(GERD)¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó2021. ÆƲ

ÊÔ½¸Éô

µÕήÀ­¿©Æ»±ê¤òÊü¤Ã¤Æ¤ª¤¯¤È¡¢¤É¤¦¤Ê¤ê¤Þ¤¹¤«¡©

Àв¬ÀèÀ¸

¿©Æ»¤ÎÇ´Ë줬Ĺ´ü´Ö¤Ë¤ï¤¿¤Ã¤Æ°ß»À¤Ë¤µ¤é¤µ¤ì¤ë¤È¡¢¿©Æ»¤ÎÇ´Ë줬ÊѲ½¤òµ¯¤³¤·¡Ö¥Ð¥ì¥Ã¥È¿©Æ»¡×¤È¸Æ¤Ð¤ì¤ë¾õÂ֤ˤʤê¤Þ¤¹¡£¥Ð¥ì¥Ã¥È¿©Æ»¤Ï¿©Æ»Á£¤¬¤ó¤ÎȯÀ¸ÊìÃϤȤʤ뤳¤È¤¬ÃΤé¤ì¤Æ¤¤¤Æ¡¢Ãí°Õ¤¬É¬ÍפǤ¹¡£¡Ö¿©Æ»Á£¤¬¤ó¡×¤Ï²¤Êƽô¹ñ¤Ç¤Ï¿¤¤¤â¤Î¤Î¡¢Ä¹Ç¯ÆüËܤˤª¤¤¤Æ¤Ï¡¢¿©Æ»¤¬¤ó¤Ç¤¹¤È°û¼ò¤äµÊ±ì¤Ëȼ¤¦¡Ö¿©Æ»Ù¨Ê¿¾åÈ餬¤ó¡×¤¬°µÅÝŪ¤Ë¿¤«¤Ã¤¿¤Î¤Ç¤¹¡£½¾Íè¡Ö¿©Æ»Á£¤¬¤ó¡×¤Ïµ©¤È¤µ¤ì¤Æ¤¤¤Þ¤·¤¿¤¬¡¢¶áǯÁý²Ã·¹¸þ¤Ë¤¢¤ë¤³¤È¤¬»ØŦ¤µ¤ì¤Æ¤¤¤Þ¤¹¡Ê¢¨2¡Ë¡£ÆüËܤˤª¤±¤ë¿©Æ»¤¬¤ó¤Î·¹¸þ¤â²¤ÊƲ½¤·¤Æ¤­¤Æ¤¤¤ë¤È¸À¤¨¤Þ¤¹¤Í¡£

¢¨2. Koizumi S, et al. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan. J Gastroenterol. 2018;53:827-33.

µÕήÀ­¿©Æ»±ê¤Î¾É¾õ¤È¼£ÎÅ

ÊÔ½¸Éô

µÕήÀ­¿©Æ»±ê¤Î¶»¾Æ¤±¤äÆÝ»À¾É¾õ°Ê³°¤Î¾É¾õ¤Ï¤¢¤ê¤Þ¤¹¤«¡©

Àв¬ÀèÀ¸

µÕήÀ­¿©Æ»±ê¤Ç¤Ï¡¢Åµ·¿Åª¤Ê¶»¾Æ¤±¡¦ÆÝ»À¾É¾õ¤Î¤Û¤«¤Ë¤â¡¢¿´Â¡É¤ȴְã¤ï¤ì¤ë¤è¤¦¤Ê¶»¤ÎÄˤߤ䡢¸ÆµÛ´ï¤Îɵ¤¤È´Ö°ã¤ï¤ì¤ë¤è¤¦¤Ê³±¾É¾õ¡¢¼ªÉ¡°ö¹¢²ÊÎΰè¤Îɵ¤¤È´Ö°ã¤ï¤ì¤ë¤è¤¦¤Ê¹¢¤ÎÄˤߤʤɡ¢Â¿ºÌ¤Ê¾É¾õ¤òÄ褹¤ë¾ì¹ç¤¬¤¢¤ê¤Þ¤¹¡£¤³¤ì¤é¤Î¾É¾õ¤ËÂФ¹¤ë°ìÈÌŪ¤Ê¸¡ºº¤Ç¸¶°ø¤¬¸«¤Ä¤«¤é¤Ê¤¤¾ì¹ç¤Ë¤Ï¡¢°ìÅپò½´ïÆâ²Ê¤ò¼õ¿Ç¤·¤Æ¤ß¤ë¤È¤è¤¤¤«¤â¤·¤ì¤Þ¤»¤ó¡£

ÊÔ½¸Éô

µÕήÀ­¿©Æ»±ê¤Î¼£ÎŤϤɤó¤Ê¤â¤Î¤¬¤¢¤ê¤Þ¤¹¤«¡©

Àв¬ÀèÀ¸

¼ç¤Ë¡ÖÀ¸³è½¬´·²þÁ±¡×¤È¡ÖÌôʪ¼£ÎšפÎ2¤Ä¤¬¼£ÎŤÎÃì¤È¤Ê¤ê¤Þ¤¹¡£ÆäËÀ¸³è½¬´·¤Ë¤ª¤¤¤Æ¤Ï¸ºÎ̤¬¸ú²ÌŪ¤Ç¡¢¡Ö²áÂνŤξì¹ç¡¢10%ÂνŤòÍî¤È¤¹¤È80%¤Î´µ¼Ô¤µ¤ó¤Ï¾É¾õ¤¬·Ú²÷¤·¡¢¤Ê¤ó¤È65%¤Î´µ¼Ô¤µ¤ó¤ÏÌô¤ò»È¤ï¤Ê¤¯¤Æ¤â´°Á´¤Ë¾É¾õ¤¬¾Ã¼º¤·¤¿¡×¤È¤¤¤¦¸¦µæ·ë²Ì¤âÊó¹ð¤µ¤ì¤Æ¤¤¤Þ¤¹¡Ê¢¨3¡Ë¡£¤½¤Î¾¡¢°û¼ò¤äµÊ±ì½¬´·¡¢¿©»öÆâÍƤθ«Ä¾¤·¤Ê¤É¤Ë¤è¤Ã¤Æ¤â¾É¾õ¤Î²þÁ±¤ò¸«¹þ¤á¤Þ¤¹¡£

¢¨3. Singh M, et al. Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial. Obesity (Silver Spring). 2013;21:284-90.

ÊÔ½¸Éô

À¸³è½¬´·¤Ëµ¤¤ò¤Ä¤±¤Æ¤â¾É¾õ¤¬²þÁ±¤·¤Ê¤¤¾ì¹ç¤Ï¤É¤¦¤·¤¿¤é¤è¤¤¤Ç¤¹¤«¡©

Àв¬ÀèÀ¸

»ÀʬÈçÍÞÀ©Ìô(°ß»À¤ÎʬÈç¤ò¤ª¤µ¤¨¤ëÌô)¤òÃæ¿´¤È¤·¤¿Ìôʪ¼£ÎŤò¤ª¤³¤Ê¤¦¤Î¤¬°ìÈÌŪ¤Ç¤¹¡£¶áǯ¤Ï¶¯ÎϤÊÌô¤â³«È¯¤µ¤ì¡¢¼£ÎÅÀ®ÀÓ¤â¸þ¾å¤·¤Æ¤¤¤Þ¤¹¤«¤é¡Ê¢¨4¡Ë¡¢¾É¾õ¤¬Â³¤¯¾ì¹ç¤Ï¤ª¶á¤¯¤ÎÆâ²Ê¤Þ¤¿¤Ï¾Ã²½´ïÆâ²Ê¤Î¼õ¿Ç¤ò¤ª¤¹¤¹¤á¤·¤Þ¤¹¡£

¢¨4. Hoshino S, et al. Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis. Digestion. 2017;95:156-161.

¾É¾õ¤¬¤Ê¤¤µÕήÀ­¿©Æ»±ê¤â¤¢¤ë⁉︎ ¾É¾õ¤¬¤Ê¤¤¾ì¹ç¤Ï¤É¤¦¤·¤¿¤é¤¤¤¤¤Î¤«

ÊÔ½¸Éô

¾É¾õ¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡¢Æâ»ë¶À¸¡ºº¤ò¤ª¤³¤Ê¤Ã¤¿¤é¡ÖµÕήÀ­¿©Æ»±ê¡×¤È¿ÇÃǤµ¤ì¤Þ¤·¤¿¡£¤É¤¦¤·¤¿¤é¤è¤¤¤Ç¤¹¤«¡©

Àв¬ÀèÀ¸

Æâ»ë¶À¸¡¿Ç¤¬ÉáµÚ¤·¡¢Ìµ¾É¾õ¤Î¡ÖµÕήÀ­¿©Æ»±ê¡×¤ò»ØŦ¤µ¤ì¤ë¥±ー¥¹¤¬Áý¤¨¤Æ¤¤¤Þ¤¹¡£¼Â¤Ï¡ÖµÕήÀ­¿©Æ»±ê¡×¤Ï¿©Æ»¤Ë±ê¾É¤òµ¯¤³¤·¤Æ¤¤¤ë¡Ö¾õÂ֡פò¤¢¤é¤ï¤¹¤â¤Î¤Ç¡¢¾É¾õ¤Î¤¢¤ë¡Ö°ß¿©Æ»µÕή¾É¡×¤È¤Ï¸·Ì©¤Ë¤Ï°Û¤Ê¤ë¤â¤Î¤Ç¤¹¡£¤·¤«¤·¡¢¡Ö°ß¿©Æ»µÕή¾É¡×¤È¤¤¤¦¸ÀÍդϰìÈ̤ÎÊý¤Ë¤Ï¤¢¤Þ¤êÆëÀ÷¤ß¤¬¤Ê¤¤¤¿¤á¡¢¾É¾õ¤Î̵ͭ¤Ë´Ø¤ï¤é¤º¡ÖµÕήÀ­¿©Æ»±ê¡×¤ÎÍѸì¤ò»ÈÍѤµ¤ì¤Æ¤¤¤ë¥±ー¥¹¤¬Â¿¤¯¡¢º®Íð¤Î¸µ¤È¤Ê¤Ã¤Æ¤¤¤Þ¤¹¡£¾É¾õ¤¬¤Ê¤¤¾ì¹ç¤Ïɬ¤º¤·¤âÌôʪ¼£ÎŤÏɬÍפǤϤ¢¤ê¤Þ¤»¤ó¤«¤é¡¢¤Þ¤º¤ÏÀ¸³è½¬´·¤Î²þÁ±¤ò¿´³Ý¤±¤Æ¤¯¤À¤µ¤¤¡£

ÊÔ½¸Éô

¡Ö¥Ð¥ì¥Ã¥È¿©Æ»¡×¤È¿ÇÃǤµ¤ì¤¿¤Î¤Ç¤¹¤¬¡¢¼£¤¹¤Ë¤Ï¤É¤¦¤·¤¿¤é¤è¤¤¤Ç¤¹¤«¡©

Àв¬ÀèÀ¸

»ÄÇ°¤Ê¤¬¤é¡¢¡Ö¥Ð¥ì¥Ã¥È¿©Æ»¡×¤ÏÉԲĵÕŪ¤ÊÊѲ½¤Ç¡¢¸µÄ̤ê¤Ë¤Ê¤ë¤³¤È¤Ï¤¢¤ê¤Þ¤»¤ó¡£¤³¤ì°Ê¾å°­²½¤·¤Ê¤¤¤è¤¦¤Ë¡¢Æü¡¹¤ÎÀ¸³è½¬´·¤Î¸«Ä¾¤·¤ò¤ª¤¹¤¹¤á¤·¤Þ¤¹¡£¤¿¤À¤·¡¢ÆüËܤÎÆâ»ë¶À¿ÇÃÇÀºÅÙ¤ÏÈó¾ï¤Ë¹â¤¤¤¿¤á¡¢³¤³°¤Ç¤Ï¡Ö¥Ð¥ì¥Ã¥È¿©Æ»¡×¤È¤Ï¿ÇÃǤµ¤ì¤Ê¤¤¤è¤¦¤Ê¡¢¤´¤¯¤ï¤º¤«¤ÊÇ´ËìÊѲ½¤òª¤¨¤Æ¿ÇÃǤµ¤ì¤Æ¤¤¤ë¾ì¹ç¤â¿¤¤¤¿¤á¡¢1ǯ¤Ë1²ó¤ÎÆâ»ë¶À¸¡ºº¤ÇŬÀڤ˷вá´Ñ»¡¤ò¤ª¤³¤Ê¤Ã¤Æ¤¤¤ì¤Ð¡¢²á¾ê¤Ë¿´ÇÛ¤¹¤ëɬÍפϤ¢¤ê¤Þ¤»¤ó¡£

ÊÔ½¸Éô

¾É¾õ¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡¢¡Ö¥Ð¥ì¥Ã¥È¿©Æ»¡×¤ä¡Ö¿©Æ»Á£¤¬¤ó¡×¤Î¥ê¥¹¥¯¤Ë¤Ê¤ë¤Èʹ¤¯¤È¡¢Í½ËÉŪ¤ËÌô¤ò°û¤ß¤¿¤¤¤È»×¤¤¤Þ¤¹¤¬¤É¤¦¤Ç¤¹¤«¡©

Àв¬ÀèÀ¸

¾É¾õ¤¬¤Ê¤¤¾ì¹ç¤ÎͽËÉŪ¤ÊÆâÉþ¤Ï¤ª¤¹¤¹¤á¤·¤Þ¤»¤ó¡£À©»ÀºÞ¤ÏÈæ³ÓŪ°ÂÁ´À­¤Î¹â¤¤Ìô¤Ç¤Ï¤¢¤ê¤Þ¤¹¤¬¡¢Ä¹´ü´ÖÆâÉþ¤ò³¤±¤¿¾ì¹ç¤Ë¤µ¤Þ¤¶¤Þ¤ÊÊÀ³²¤¬½Ð¤ë²ÄǽÀ­¤¬¶áǯ»ØŦ¤µ¤ì¤Æ¤¤¤Þ¤¹¡£Î㤨¤Ð¾­ÍèŪ¤ÊǧÃξɤÎȯ¾É¥ê¥¹¥¯¤òÁý²Ã¤µ¤»¤¿¤ê¡¢¾Ã²½µÛ¼ýǽÎϤËÊѲ½¤òµÚ¤Ü¤·¤¿¤ê¡¢Ä²ÆâºÙ¶ÝÁѤËÊѲ½¤òÍ¿¤¨¤¿¤ê¤Ê¤É¤¬µó¤²¤é¤ì¤Þ¤¹¡£¤³¤ì¤é¤ÎÊÀ³²¤Ï¤¢¤¯¤Þ¤ÇĹ´ü´ÖÉþÍѤò³¤±¤¿¾ì¹ç¤Î¤â¤Î¤Ç¤¹¤«¤é¡¢¾É¾õ¤¬¤Ä¤é¤¤»þ¤Îû´üŪ¤Ê»ÈÍѤòí´í°¤¹¤ëɬÍפÏÁ´¤¯¤¢¤ê¤Þ¤»¤ó¤¬¡¢Ìô¤Î»ÈÍѤÏɬÍ׺ÇÄã¸Â¤Ë¤È¤É¤á¤Æ¡¢À¸³è½¬´·¤Î²þÁ±¤Ë¤è¤Ã¤Æ¤è¤¤¾õÂÖ¤òÊݤƤë¤è¤¦¤Ë¤·¤¿¤¤¤Ç¤¹¤Í¡£

ÊÔ½¸Éô¤Þ¤È¤á

µÕήÀ­¿©Æ»±ê¤Ï¶»¾Æ¤±¤äÆÝ»À¾É¾õ¤òÃæ¿´¤ËÍÍ¡¹¤Ê¾É¾õ¤òÄ褷¡¢¿©Æ»Á£¤¬¤ó¤ÎȯÀ¸¤Ë¤â´Ø¤ï¤ê¤Þ¤¹¡£»×¤¤Åö¤¿¤ë¾É¾õ¤¬¤¢¤ë¾ì¹ç¤Ï¡¢¾Ã²½´ïÆâ²Ê¤ò¼õ¿Ç¤·¿ÇÃǤȼ£ÎŤò¼õ¤±¤Þ¤·¤ç¤¦¡£¤Þ¤¿ÂνŴÉÍý¤ä°û¼ò¡¦µÊ±ì¤Ê¤É¤ÎÀ¸³è½¬´·¤ò¸«Ä¾¤¹¤³¤È¤âÍ­¸ú¤Ç¤¹¤Î¤Ç¡¢ÉÔÀÝÀ¸¤Î¤Ê¤¤À¸³è¤ò¿´³Ý¤±¤Þ¤·¤ç¤¦¡£

¶á¤¯¤Î¾Ã²½´ïÆâ²Ê¤òõ¤¹